Hyperfine (HYPR) Cash from Operations (2021 - 2026)
Hyperfine (HYPR) posted Cash from Operations of 9008000.0 for Q1 2026, down 73.0% on a QoQ basis from 5207000.0 in Q4 2025, and up 2.61% year-over-year from 8779240.46 in Q1 2025.
Hyperfine (HYPR) Cash from Operations (2021 - 2026) Analysis & Trends
Hyperfine's Cash from Operations history runs 6 years deep, the most recent figure standing at 9008000.0 for Q1 2026.
- Quarterly Cash from Operations rose 2.61% year-over-year to 9008000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 27707000.0 (up 21.97% YoY) and the FY2025 annual result came in at 27948000.0, up 27.91% from the prior year.
- Cash from Operations was 9008000.0 for Q1 2026 at Hyperfine, down from 5207000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 5207000.0 in Q4 2025 and bottomed at 27289000.0 in Q1 2022.
- A 5-year average of 11168882.35 and a median of 9383000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 264.53% — and 2023, when it jumped 50.56%.
- Hyperfine's Cash from Operations stood at 15345000.0 in 2022, then soared by 35.24% to 9938000.0 in 2023, then rose by 15.91% to 8357000.0 in 2024, then surged by 37.69% to 5207000.0 in 2025, then sank by 73.0% to 9008000.0 in 2026.
- Business Quant data shows HYPR's Cash from Operations at 9008000.0 in Q1 2026, 5207000.0 in Q4 2025, and 5582000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | -9.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.01 Mn |
| Mar 31, 2026 | -9.01 Mn |
| Dec 31, 2025 | -5.21 Mn |
| Dec 31, 2025 | -5.21 Mn |
| Sep 30, 2025 | -5.58 Mn |
| Sep 30, 2025 | -5.58 Mn |
| Jun 30, 2025 | -7.91 Mn |
| Jun 30, 2025 | -7.91 Mn |
| Mar 31, 2025 | -9.25 Mn |
| Mar 31, 2025 | -9.25 Mn |
| Dec 31, 2024 | -8.36 Mn |
| Dec 31, 2024 | -8.36 Mn |
| Sep 30, 2024 | -8.52 Mn |
| Sep 30, 2024 | -8.52 Mn |
| Jun 30, 2024 | -9.38 Mn |
| Jun 30, 2024 | -9.38 Mn |
| Mar 31, 2024 | -12.51 Mn |
| Mar 31, 2024 | -12.51 Mn |
| Dec 31, 2023 | -9.94 Mn |
| Dec 31, 2023 | -9.94 Mn |